ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 73 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $62,000 | -53.0% | 60,400 | -36.9% | 0.00% | – |
Q2 2021 | $132,000 | -23.7% | 95,700 | -5.9% | 0.00% | – |
Q1 2021 | $173,000 | +16.1% | 101,725 | +77.8% | 0.00% | – |
Q4 2016 | $149,000 | +156.9% | 57,200 | +163.4% | 0.00% | – |
Q2 2016 | $58,000 | -14.7% | 21,718 | -1.4% | 0.00% | – |
Q1 2016 | $68,000 | -69.8% | 22,018 | -62.3% | 0.00% | – |
Q4 2015 | $225,000 | +5.1% | 58,346 | +49.8% | 0.00% | – |
Q3 2014 | $214,000 | -46.4% | 38,937 | 0.0% | 0.00% | – |
Q2 2014 | $399,000 | -44.4% | 38,937 | -34.8% | 0.00% | – |
Q1 2014 | $717,000 | – | 59,735 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Values First Advisors, Inc. | 250,110 | $528,000 | 0.51% |
XTX MARKETS LLC | 12,925 | $27,000 | 0.19% |
Cornerstone Capital, Inc. | 491,560 | $1,037,000 | 0.15% |
Aristides Capital LLC | 64,482 | $136,000 | 0.10% |
LINCOLN CAPITAL CORP | 57,000 | $120,000 | 0.09% |
HighVista Strategies LLC | 41,400 | $87,000 | 0.07% |
Ahrens Investment Partners LLC | 61,500 | $130,000 | 0.05% |
J Arnold Wealth Management Co | 18,000 | $38,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 114,437 | $241,000 | 0.03% |
Avidian Wealth Solutions, LLC | 63,000 | $133,000 | 0.02% |